PMED — Peptonic Medical AB Share News
0.000.00%
Last trade - 00:00- SEK22.06m
- SEK24.29m
- SEK14.79m
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts
Brief: Peptonic Medical FY Sales SEK 14.788 Million
Brief: Peptonic Medical Requests Extension Of Corporate Reconstruction Until Dec 15, 2025
Brief: Peptonic Medical Says Request For Extension Of Company Reconstruction And Update On The Reconstruction Process
Brief: Peptonic Medical AB Says Intends To Submit A Request For Extension Of Ongoing Corporate Restructuring
Brief: Peptonic Medical Says Co. Offers 70% Debt Write-Off To Unsecured Creditors
Brief: Peptonic Medical Establishes Subsidiary In US
Brief: Peptonic Says Court Approves Peptonic Medical's Corporate Restructuring Application
Brief: Peptonic Medical Says Co Files For Corporate Restructuring
Brief: Peptonic Medical Says Co Closes Its Israeli Subsidiary
Brief: Peptonic Says Resolves, Subject To Approval Of The General Meeting, On A Rights Issue Of Units Of Approximately SEK 61.4 Mln
Brief: Peptonic Medical Q3 Sales at SEK 9.525 Million
Brief: Peptonic Medical Q2 Sales at SEK 11.93 Million
Brief: Peptonic Signs License Agreement With Prima Lab Regarding Menopause Test
Brief: Pharmiva, Peptonic Announce Merger Plan
Brief: Peptonic Signs Lunette Distribution Agreement With UCC For Australian Market